Keppra (generic name: Levetiracetam) is an anticonvulsant used in the treatment of epilepsy.
Keppra is indicated in epileptic patients as add-on therapy in the treatment of primary generalized tonic-clonic seizures in adults and children 6 years of age and older with idiopathic generalized epilepsy, myoclonic seizures in patients 12 years of age and older with juvenile myoclonic epilepsy, and partial onset seizures in patients 4 years of age and older.
Keppra works by decreasing abnormal excitement in the brain.
Keppra is non-addictive. Keppra is generally well tolerated.
Keppra was shown to be beneficial even for patients who experienced repeated seizures after trying many different treatments (this is referred to as refractory epilepsy).
Keppra has no known clinically significant drug interactions; it has been shown to be safe when used with other antiepilepsy medicines and with everyday drugs such as birth control pills or warfarin.
Keppra is not broken down in the liver, unlike many other antiepilepsy medicines.
This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.